Miller Anestesia

for transthoracic ventricular defibrillation. Trans-

thoracic Investigators. Circulation 94:2507, 1996.

109. Schneider T, Martens PR, Paschen H, et al: Multi-

center, randomized, controlled trial of 150-J bipha-

sic shocks compared with 200- to 360-J monophasic

shocks in the resuscitation of out-of-hospital

cardiac arrest victims. Optimized Response to

Cardiac Arrest (ORCA) Investigators. Circulation

102:1780, 2000.

110. Cummins RO, Hazinski MF, Kerber RE, et al: Low-

energy biphasic waveform defibrillation: Evidence-

based review applied to emergency cardiovascular

care guidelines: A statement for healthcare profes-

sionals from the American Heart Association Com-

mittee on Emergency Cardiovascular Care and the

Subcommittees on Basic Life Support, Advanced

Cardiac Life Support, and Pediatric Resuscitation.

Circulation 97:1654, 1998.

111. White RD, Hankins DG, Atkinson EJ: Patient outco-

mes following defibrillation with a low energy

biphasic truncated exponential waveform in out-of-

hospital cardiac arrest. Resuscitation 49:9, 2001.

112. van Alem AP, Chapman FW, Lank P, et al: A pros-

pective, randomised and blinded comparison of

first shock success of monophasic and biphasic

waveforms in out-of-hospital cardiac arrest. Resus-

citation 58:17, 2003.

113. White RD: Early out-of-hospital experience with an

impedance-compensating low-energy biphasic

waveform automatic external defibrillator. J Interv

Card Electrophysiol 1:203, 1997.

114. Morrison LJ, Dorian P, Long J, et al: Out-of-hospital

cardiac arrest rectilinear biphasic to monophasic

damped sine defibrillation waveforms with advan-

ced life support intervention trial (ORBIT). Resus-

citation 66:149, 2005.

115. Walsh SJ, McClelland AJ, Owens CG, et al: Efficacy

of distinct energy delivery protocols comparing two

biphasic defibrillators for cardiac arrest. Am J

Cardiol 94:378, 2004.

116. Handbook of Emergency: Cardiovascular Care for

Healthcare Providers. Dallas, AmericanHeart Asso-

ciation, 2006.

117. White RD, Blackwell TH, Russell JK, et al: Body

weight does not affect defibrillation, resuscitation,

or survival in patients with out-of-hospital cardiac

arrest treated with a nonescalating biphasic wave-

form defibrillator. Crit Care Med 32:S387, 2004.

118. Biboulet P, Aubas P, Dubourdieu J, et al: Fatal and

non fatal cardiac arrests related to anesthesia. Can

J Anaesth 48:326, 2001.

119. Newland MC, Ellis SJ, Lydiatt CA, et al: Anesthetic-

related cardiac arrest and its mortality: A report

covering 72,959 anesthetics over 10 years from a US

teaching hospital. Anesthesiology 97:108, 2002.

120. Caplan RA, Ward RJ, Posner K, et al: Unexpected

cardiac arrest during spinal anesthesia: A closed

claims analysis of predisposing factors. Anesthesio-

logy 68:5, 1988.

121. Keats AS: Anesthesia mortality: A new mechanism.

Anesthesiology 68:2, 1988.

122. Schwid HA, O’Donnell DO: Anesthesiologists’

management of simulated critical incidents. Anes-

thesiology 76:495, 1992.

123. Semeraro F, Signore L, Cerchiari EL: Retention of

CPR performance in anaesthetists. Resuscitation

68:101, 2006.

124. White RD: Pharmacologic management of arrhyth-

mias during advanced cardiac life support. Anesthe-

siol Clin North Am 13:849, 1995.

125. Mackey DC, Carpenter RL, Thompson GE, et al:

Bradycardia and asystole during spinal anesthesia:

A report of three cases without morbidity. Anesthe-

siology 70:866, 1989.

126. Gonzalez ER: Pharmacologic controversies in CPR.

Ann Emerg Med 22:317, 1993.

127. Brown DL, Carpenter RL, Moore DC, et al: Cardiac

arrest during spinal anesthesia. III. Anesthesiology

68:971, 1988.

128. Falk RH, Zoll PM, Zoll RH: Safety and efficacy of

noninvasive cardiac pacing: A preliminary report.

N Engl J Med 309:1166, 1983.

129. Berliner D, Okun M, Peters RW, et al: Transcuta-

neous temporary pacing in the operating room.

JAMA 254:84, 1985.

130. Smith I, Monk TG, White PF: Comparison of tran-

sesophageal atrial pacing with anticholinergic drugs

for the treatment of intraoperative bradycardia.

Anesth Analg 78:245, 1994.

131. Atlee JL 3rd, Pattison CZ, Mathews EL, et al: Tran-

sesophageal atrial pacing for intraoperative sinus

bradycardia or AV junctional rhythm: Feasibility as

prophylaxis in 200 anesthetized adults and hemo-

dynamic effects of treatment. J Cardiothorac Vasc

Anesth 7:436, 1993.

132. Lim SH, Anantharaman V, Teo WS, et al: Compari-

son of treatment of supraventricular tachycardia by

Valsalva maneuver and carotid sinus massage. Ann

Emerg Med 31:30, 1998.

133. Rankin AC, Brooks R, Ruskin JN, et al: Adenosine

and the treatment of supraventricular tachycardia.

Am J Med 92:655, 1992.

134. Camm AJ, Garratt CJ: Adenosine and supraventri-

cular tachycardia. N Engl J Med 325:1621, 1991.

135. DiMarco JP, Sellers TD, Lerman BB, et al: Diagnos-

tic and therapeutic use of adenosine in patients with

supraventricular tachyarrhythmias. J Am Coll

Cardiol 6:417, 1985.

136. DiMarco JP, Sellers TD, Berne RM, et al: Adenosine:

Electrophysiologic effects and therapeutic use for

terminating paroxysmal supraventricular tachycar-

dia. Circulation 68:1254, 1983.

137. Belardinelli L, Linden J, Berne RM: The cardiac

effects of adenosine. Prog Cardiovasc Dis 32:73,

1989.

138. Lerman BB, Belardinelli L: Cardiac electrophysio-

logy of adenosine. Basic and clinical concepts. Cir-

culation 83:1499, 1991.

139. Rankin AC, Oldroyd KG, Chong E, et al: Value and

limitations of adenosine in the diagnosis and

treatment of narrow and broad complex tachycar-

dias. Br Heart J 62:195, 1989.

140. Griffith MJ, Linker NJ, Ward DE, et al: Adenosine in

the diagnosis of broad complex tachycardia. Lancet

1:672, 1988.

141. Sharma AD, Klein GJ, Yee R: Intravenous adenosine

triphosphate during wide QRS complex tachycar-

dia: Safety, therapeutic efficacy, and diagnostic

utility. Am J Med 88:337, 1990.

142. McIntosh-Yellin NL, Drew BJ, Scheinman MM:

Safety and efficacy of central intravenous bolus

administration of adenosine for termination of

supraventricular tachycardia. J Am Coll Cardiol

22:741, 1993.

143. White RD: Acceleration of the ventricular response

in paroxysmal lone atrial fibrillation following the

injection of adenosine. Am J Emerg Med 11:245,

1993.

144. Slade AK, Garratt CJ: Proarrhythmic effect of ade-

nosine in a patient with atrial flutter. Br Heart J

70:91, 1993.

145. Brodsky MA, Allen BJ, Grimes JA, et al: Enhanced

atrioventricular conduction during atrial flutter

after intravenous adenosine. N Engl J Med 330:288,

1994.

146. Brodsky MA, Hwang C, Hunter D, et al: Life-threa-

tening alterations in heart rate after the use of ade-

nosine in atrial flutter. Am Heart J 130:564, 1995.

147. Shen WK, Kurachi Y: Mechanisms of adenosine-

mediated actions on cellular and clinical cardiac

electrophysiology. Mayo Clin Proc 70:274, 1995.

148. Lerman BB, Wesley RC, Belardinelli L: Electrophy-

siologic effects of dipyridamole on atrioventricular

nodal conduction and supraventricular tachycardia.

Role of endogenous adenosine. Circulation 80:1536,

1989.

149. German DC, Kredich NM, Bjornsson TD: Oral

dipyridamole increases plasma adenosine levels in

human beings. Clin Pharmacol Ther 45:80, 1989.

150. DeGroff CG, Silka MJ: Bronchospasm after intrave-

nous administration of adenosine in a patient with

asthma. J Pediatr 125:822, 1994.

151. Drake I, Routledge PA, Richards R: Bronchospasm

induced by intravenous adenosine. Hum Exp

Toxicol 13:263, 1994.

152. Bennett-Guerrero E, Young CC: Bronchospasm

after intravenous adenosine administration. Anesth

Analg 79:386, 1994.

153. Aggarwal A, Farber NE, Warltier DC: Intraoperative

bronchospasm caused by adenosine. Anesthesio-

logy 79:1132, 1993.

154. Waxman HL, Myerburg RJ, Appel R, et al: Verapamil

for control of ventricular rate in paroxysmal supra-

ventricular tachycardia and atrial fibrillation or

flutter: A double-blind randomized cross-over

study. Ann Intern Med 94:1, 1981.

155. McGovern R, Garan H, Ruskin JN: Precipitation of

cardiac arrest by verapamil in patients with Wolff-

Parkinson-White syndrome. Ann Intern Med

104:791, 1986.

156. Gulamhusein S, Ko P, Carruthers SG, et al: Accele-

ration of the ventricular response during atrial

fibrillation in the Wolff-Parkinson-White syndrome

after verapamil. Circulation 65:348, 1982.

157. Garratt C, Antoniou A, Ward D, et al: Misuse of

verapamil in preexcited atrial fibrillation. Lance

1:367, 1989.

158. Stambler BS, Wood MA, Ellenbogen KA, et al: Effi-

cacy and safety of repeated intravenous doses of

ibutilide for rapid conversion of atrial flutter or

fibrillation. Ibutilide Repeat Dose Study Investiga-

tors. Circulation 94:1613, 1996.

159. Stambler BS, Beckman KJ, Kadish AH, et al: Acute

hemodynamic effects of intravenous ibutilide in

patients with or without reduced left ventricular

function. Am J Cardiol 80:458, 1997.

160. Scher DL, Arsura EL: Multifocal atrial tachycardia:

mechanisms, clinical correlates, and treatment. Am

Heart J 118:574, 1989.

161. Varriale P, David W, Chryssos BE: Multifocal atrial

arrhythmia—a frequent misdiagnosis? A correlative

study using the computerized ECG. Clin Cardiol

15:343, 1992.

162. Schwartz M, Rodman D, Lowenstein SR: Recogni-

tion and treatment of multifocal atrial tachycardia:

A critical review. J Emerg Med 12:353, 1994.

163. White RD: Prehospital recognition of multifocal

atrial tachycardia: Association with acute myocar-

dial infarction. Ann Emerg Med 21:753, 1992.

164. Strickberger SA, Miller CB, Levine JH: Multifocal

atrial tachycardia from electrolyte imbalance. Am

Heart J 115:680, 1988.

165. NaccarelliGV,

JalalS:Intravenousamiodarone.Another

optionintheacutemanagementofsustainedventricular

tachyarrhythmias. Circulation 92:3154, 1995.

166. Kowey PR, Levine JH, Herre JM, et al: Randomized,

double-blind comparison of intravenous amioda-

rone and bretylium in the treatment of patients with

recurrent, hemodynamically destabilizing ventricu-

lar tachycardia or fibrillation. The Intravenous

Amiodarone Multicenter Investigators Group. Cir-

culation 92:3255, 1995.

Reanimación cardiopulmonar: soporte vital básico y avanzado

2765

Sección VII

Cuidados críticos